Masanori Oshi

34PUBLICATIONS
35CO-AUTHORS
Haematological tumoursCommunications engineering not elsewhere classifiedCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 28, 2026
Clinical and Local Immune Factors Associated With Pleurodesis Outcomes in Breast Cancer Patients With Malignant Pleural Effusion: A Retrospective Study.

|Aug 13, 2026
Correction: Tokumaru et al. High Expression of microRNA-143 Is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer. Int. J. Mol. Sci. 2020, 21, 3213.

|Jul 31, 2026
Molecular dichotomy of mucinous carcinoma defined by the presence of solid papillary carcinoma components: an integrative transcriptomic analysis.

|Jun 25, 2026
A Multiresolution Breast Cancer CIBERSORTx Resource Validated for Accuracy, Interpretive Limits, and Biological and Clinical Coherence in Tumor Microenvironment Deconvolution.

|Dec 04, 2025
Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study.

Masanori Oshi, Tomo Nakayama, Ichiro Ota

|Jul 25, 2025
Unique Biological Characteristics of Patients with High Gleason Score and Localized/Locally Advanced Prostate Cancer Using an In Silico Translational Approach.

Shiori Miyachi, Masanori Oshi, Takeshi Sasaki

Pageof 6

Frequent Collaborators

29 joint publications

Kazuaki Takabe

20 joint publications

Yoshihisa Tokumaru

4 joint publications

Eriko Katsuta

3 joint publications

Maiko Okano